Home Outcomes of newborns screened for congenital hypothyroidism in Turkey – a single center experience
Article
Licensed
Unlicensed Requires Authentication

Outcomes of newborns screened for congenital hypothyroidism in Turkey – a single center experience

  • Ihsan Esen ORCID logo EMAIL logo , Nilgun Eraslan and Deniz Okdemir
Published/Copyright: November 14, 2024

Abstract

Objectives

It was aimed to investigate the outcomes of babies referred to a tertiary health center in Turkey for evaluation primary congenital hypothyroidism (CH) through newborn screening.

Methods

The hospital files of 328 newborns who were referred for CH from newborn screening between June 2013 and June 2020 were retrospectively reviewed. The newborns were evaluated with their clinical characteristics at admission, as well as their follow-up data and final diagnoses.

Results

Sixteen (4.9 %) newborns were diagnosed with transient neonatal hyperthyrotropinemia after follow-up. Treatment was initiated in 166 (50.6 %) of the cases with a diagnosis of CH. The median age at initiation of treatment was 17 days (5–69). Treatment was initiated in 88.3 % of the cases in the first month of the life. After at least 3 years of follow-up, 30/120 (20.0 %) of the cases were diagnosed with permanent CH and 11/30 (36.7 %) of them were diagnosed with thyroid dysgenesis. All of the cases who used >37.5 µg per day levothyroxine at the age of 1 or 2 years were diagnosed with permanent CH during their follow-up. For the prediction of transient CH, the sensitivity and specificity of levothyroxine doses of ≤25 µg per day at 1 year of age were calculated as 96.2 and 46.2 %, and for 2 years of age, the sensitivity and specificity were calculated as 97.8 and 65.2 %.

Conclusions

In this cohort, 10 % of all referrals result in permanent CH. Thyroid imaging with ultrasonography and levothyroxine dose during follow-up can be guiding in predicting permanent CH.


Corresponding author: Ihsan Esen, Prof., Department of Pediatric Endocrinology, Chair of Pediatrics, Medical School of Firat University, Üniversite Mahallesi Yahya Kemal Caddesi No:25, 34410 Elazig, Türkiye, E-mail:
Ihsan Esen and Nilgun Eraslan contributed equally to this work and share first authorship.
  1. Research ethics: Ethical approval for the study was obtained from the local Ethics Committee date 04.02.2021 and document ID 2021/02 -43. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).

  2. Informed consent: Not applicable.

  3. Author contributions: All the authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by IE and NE. The first draft of the manuscript was written by IE, and all the authors commented on previous versions of the manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Olivieri, A, Fazzini, C, Medda, E, Italian Study Group for Congenital H. Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr 2015;83:86–93. https://doi.org/10.1159/000369394.Search in Google Scholar PubMed

2. van Trotsenburg, P, Stoupa, A, Leger, J, Rohrer, T, Peters, C, Fugazzola, L, et al.. Congenital hypothyroidism: a 2020–2021 consensus guidelines update-an ENDO-European reference network initiative endorsed by the European society for pediatric endocrinology and the European society for endocrinology. Thyroid 2021;31:387–419. https://doi.org/10.1089/thy.2020.0333.Search in Google Scholar PubMed PubMed Central

3. Rose, SR, Wassner, AJ, Wintergerst, KA, Yayah-Jones, NH, Hopkin, RJ, Chuang, J, et al.. Congenital hypothyroidism: screening and management. Pediatrics 2023;151. https://doi.org/10.1542/peds.2022-060420.Search in Google Scholar PubMed

4. Dilli, D, Czbas, S, Acican, D, Yamak, N, Ertek, M, Dilmen, U. Establishment and development of a national newborn screening programme for congenital hypothyroidism in Turkey. J Clin Res Pediatr Endocrinol 2013;5:73–9. https://doi.org/10.4274/jcrpe.929.Search in Google Scholar PubMed PubMed Central

5. Ozgelen, S, Nijat Bas, V, Cetinkaya, S, Aycan, Z. What has national screening program changed in cases with congenital hypothyroidism? Iran J Pediatr 2014;24:255–60.Search in Google Scholar

6. Kara, C, Gunindi, F, Can Yilmaz, G, Aydin, M. Transient congenital hypothyroidism in Turkey: an analysis on frequency and natural course. J Clin Res Pediatr Endocrinol 2016;8:170–9. https://doi.org/10.4274/jcrpe.2345.Search in Google Scholar PubMed PubMed Central

7. Baysal, BT, Baysal, B, Genel, F, Erdur, B, Ozbek, E, Demir, K, et al.. Neurodevelopmental outcome of children with congenital hypothyroidism diagnosed in a national screening program in Turkey. Indian Pediatr 2017;54:381–4. https://doi.org/10.1007/s13312-017-1111-5.Search in Google Scholar PubMed

8. Bezen, D, Dilek, E, Torun, N, Tutunculer, F. Etiological evaluation of primary congenital hypothyroidism cases. Turk Pediatri Ars 2017;52:85–91. https://doi.org/10.5152/turkpediatriars.2017.3989.Search in Google Scholar PubMed PubMed Central

9. Kor, Y, Kor, D. Current status of the congenital hypothyroidism neonatal screening program in Adana Province, Turkey. J Pediatr Endocrinol Metab 2018;31:619–24. https://doi.org/10.1515/jpem-2017-0433.Search in Google Scholar PubMed

10. Donbaloglu, Z, Savas-Erdeve, S, Cetinkaya, S, Aycan, Z. Cases referred from the Turkish national screening program: frequency of congenital hypothyroidism and etiological distribution. J Clin Res Pediatr Endocrinol 2019;11:240–6. https://doi.org/10.4274/jcrpe.galenos.2019.2018.0255.Search in Google Scholar PubMed PubMed Central

11. Asena, M, Demiral, M, Unal, E, Ocal, M, Demirbilek, H, Ozbek, MN. Validity of six month L-thyroxine dose for differentiation of transient or permanent congenital hypothyroidism. J Clin Res Pediatr Endocrinol 2020;12:275–80. https://doi.org/10.4274/jcrpe.galenos.2020.2019.0170.Search in Google Scholar PubMed PubMed Central

12. Donbaloglu, Z, Cetinkaya, S, Aycan, Z, Karacan Kucukali, G, Sakar, M, Savas-Erdeve, S. Evaluation of permanent and transient congenital hypothyroidism in cases referred from National Neonatal Screening Program. J Paediatr Child Health 2022;58:1431–8. https://doi.org/10.1111/jpc.16025.Search in Google Scholar PubMed

13. Dundar, I, Buyukavci, MA, Ciftci, N. Etiological, clinical, and laboratory evaluation of congenital hypothyroidism and determination of levothyroxine (LT4) dose at treatment interruption in differentiating permanent vs. transient patients. Turk J Med Sci 2022;52:1863–71. https://doi.org/10.55730/1300-0144.5533.Search in Google Scholar PubMed PubMed Central

14. Toktas, I, Erdem, O, Saribas, S, Ozbek, MN. Evaluation of patients diagnosed with congenital hypothyroidism by newborn screening between 2011–2019 in Diyarbakir, Turkey. Medicine (Baltimore) 2023;102:e36778. https://doi.org/10.1097/md.0000000000036778.Search in Google Scholar PubMed PubMed Central

15. Ozer, Y, Anik, A, Sayili, U, Tercan, U, Deveci Sevim, R, Gunes, S, et al.. High frequency of transient congenital hypothyroidism among infants referred for suspected congenital hypothyroidism from the Turkish National Screening Program: thyroxine dose may guide the prediction of transients. J Endocrinol Invest 2024;47:2213–24. https://doi.org/10.1007/s40618-024-02348-9.Search in Google Scholar PubMed PubMed Central

16. Neyzi, O, Bundak, R, Gokcay, G, Gunoz, H, Furman, A, Darendeliler, F, et al.. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 2015;7:280–93. https://doi.org/10.4274/jcrpe.2183.Search in Google Scholar PubMed PubMed Central

17. Tarim, OF, Yordam, N. Congenital hypothyroidism in Turkey: a retrospective evaluation of 1000 cases. Turk J Pediatr 1992;34:197–202.Search in Google Scholar

18. Peltek Kendirci, HN, Aycan, Z, Sagsak, E, Keskin, M, Cetinkaya, S. The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism. Turk J Med Sci 2015;45:745–50. https://doi.org/10.3906/sag-1404-109.Search in Google Scholar

19. Unuvar, T, Demir, K, Abaci, A, Atas, A, Buyukgebiz, A, Bober, E. Monitoring and prognostic evaluation of patients with congenital hypothyroidism treated in a pediatric endocrinology unit. Turk J Pediatr 2013;55:384–90.Search in Google Scholar

20. Caylan, N, Tezel, B, Ozbas, S, Sahin, N, Aydin, S, Acican, D, et al.. Neonatal thyroid-stimulating hormone screening as a monitoring tool for iodine deficiency in Turkey. J Clin Res Pediatr Endocrinol 2016;8:187–91. https://doi.org/10.4274/jcrpe.2526.Search in Google Scholar PubMed PubMed Central

21. Clerc, J. Imaging the thyroid in children. Best Pract Res Clin Endocrinol Metab 2014;28:203–20. https://doi.org/10.1016/j.beem.2013.04.011.Search in Google Scholar PubMed

22. Matejek, N, Tittel, SR, Haberland, H, Rohrer, T, Busemann, EM, Jorch, N, et al.. Predictors of transient congenital primary hypothyroidism: data from the German registry for congenital hypothyroidism (AQUAPE “HypoDok”). Eur J Pediatr 2021;180:2401–8. https://doi.org/10.1007/s00431-021-04031-0.Search in Google Scholar PubMed PubMed Central

23. Messina, MF, Aversa, T, Salzano, G, Zirilli, G, Sferlazzas, C, De Luca, F, et al.. Early discrimination between transient and permanent congenital hypothyroidism in children with eutopic gland. Horm Res Paediatr 2015;84:159–64. https://doi.org/10.1159/000435811.Search in Google Scholar PubMed

Received: 2024-08-07
Accepted: 2024-10-24
Published Online: 2024-11-14
Published in Print: 2025-01-29

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Osteogenesis imperfecta: shifting paradigms in pathophysiology and care in children
  4. Opinion Paper
  5. CRH receptor antagonist crinecerfont – a promising new treatment option for patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
  6. Original Articles
  7. Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus
  8. Geographic information system mapping and predictors of glycemic control in children and youth with type 1 diabetes: a study from Western India
  9. Body composition assessment measured via bioelectrical impedance analysis in euthyroid children with newly diagnosed Hashimoto’s thyroiditis
  10. Outcomes of newborns screened for congenital hypothyroidism in Turkey – a single center experience
  11. High yield of congenital hypothyroidism among infants attending Children Hospital, Nairobi, Kenya. Facility based study in the absence of newborn screening
  12. Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients
  13. Assessment of quality of life in families affected by maple syrup urine disease: a cross sectional study
  14. Case Reports
  15. Reninoma: an unusual cause of growth failure
  16. Persistent hypoglycemia in congenital syphilis: hyperinsulinemic hypoglycemia with a focal pancreatic lesion
  17. Diagnostic challenges in pediatric Cushing’s disease associated with chronic renal failure: a report of three patients
  18. A novel de novo missense OTC mutation in an Iranian girl: a case report
Downloaded on 2.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2024-0377/html
Scroll to top button